Keyphrases
Cell Therapy
100%
T Cells
100%
Alloreactive
100%
CD-8
100%
Veto
100%
Central Memory
100%
CD8+ T Cells
62%
Deprivation
37%
T Cell Depletion
37%
Interleukin-15 (IL-15)
37%
Veto Cell
37%
Memory CD8+ T Cells
37%
Autoreactive T Cells
25%
Dendritic Cells
25%
Allogeneic
25%
Ovalbumin
25%
Interleukin-7 (IL-7)
25%
Nonmyeloablative
25%
Cytomegalovirus
25%
T Cell Clone
25%
Graft-versus-host Disease (GvHD)
25%
Allografting
25%
Phase 1/2 Clinical Trial
25%
Peripheral Blood
12%
Preclinical Data
12%
Epstein-Barr Virus
12%
Bone Marrow
12%
CD45RA
12%
Intracellular Expression
12%
CD4+
12%
Engraftment
12%
Adenovirus
12%
CD14+ Monocytes
12%
In Vitro Activity
12%
Antiviral Activity
12%
Peptide Mixtures
12%
Disease-associated
12%
Epstein-Barr Virus-positive
12%
Hematopoietic Stem Cell Transplantation
12%
Viral Peptides
12%
Enriched Fractions
12%
Chimeric Antigen Receptor T-cell Therapy
12%
Leukapheresis
12%
CD56+
12%
BK Polyomavirus (BKPyV)
12%
CD45RO
12%
Interleukin-21 (IL-21)
12%
CD62L
12%
Haploidentical
12%
Alloreactivity
12%
CD3+CD8+
12%
Viral Antigens
12%
Memory Phenotype
12%
Naïve CD8 T Cell
12%
Limiting Dilution Analysis
12%
Haploidentical Hematopoietic Stem Cell Transplantation
12%
Immunology and Microbiology
T Cell
100%
CD8
100%
Cytotoxic T-Cell
100%
Interleukin 15
42%
Cytokine
28%
Graft-Versus-Host Disease
28%
Dendritic Cell
28%
Memory T Cell
28%
Cell Clone
28%
Cytomegalovirus
28%
Interleukin 7
28%
Alloreactive T Cell
28%
Epstein Barr Virus
28%
CD4
14%
Tumor Necrosis Factor
14%
Dilution
14%
Engraftment
14%
CD14
14%
Adenoviridae
14%
Chimeric Antigen Receptor T-Cell Therapy
14%
Antiviral Activity
14%
Hematopoietic Stem Cell Transplantation
14%
BK Virus
14%
Alloimmunity
14%
Virus Antigen
14%
Leukapheresis
14%
Haploidentical Hematopoietic Stem Cell Transplantation
14%
CD3 Antigen
14%
Peptides
14%
Virus Peptides
14%